Abstract:Peroxisome proliferator-activated receptors (PPAR) are involved in the pathogenesis of insulin resistance, diabetes, hyperlipidemias, and related complications. Consequently, a mechanistic understanding of PPAR subtypes and their activation provides promising therapeutic targets for the management of type 2 diabetes mellitus and the metabolic syndrome. Available data from rodent carcinogenicity studies, however, demonstrate that PPAR agonists can be tumorigenic in one or more species of rodents at multiple sites. Sufficient data are not yet available to explain the mode(s) of action for most of these tumor types. There has been information presented by FDA that indicates there are urothelial changes in the monkey (and possibly the dog) in addition to the rat. Outstanding questions exist regarding potency, species differences, safety margins, and other issues. In 2005, the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) PPAR Agonist Project Committee was established to advance research on the modes of action and potential human relevance of emerging rodent tumor data. Additionally, the HESI PPAR Agonist Project Committee authorized a Pathology Working Group (PWG) to examine the urinary bladder from cynomolgus monkeys. The focus of this PWG was to establish consistent diagnostic criteria for urothelial changes and to assess the potential relationship of these changes to treatment. Specific diagnostic criteria and nomenclature were recommended for the diagnosis of urothelial granules, vacuolation, hypertrophy, and hyperplasia in studies conducted with PPARgamma and dual alpha/gamma agonists in cynomolgus monkeys, which will assist investigators performing toxicity studies to provide data in a consistent manner between studies and laboratories. In this review of selected tissues, treatment with PPAR agonists was not associated with urothelial hypertrophy or hyperplasia, but there was an increased incidence in the size and frequency of vacuoles within the superficial urothelial and adjacent intermediate cell layers.

Urothelial carcinogenesis and portocaval anastomosis in the rat

Mitogenic effects of propoxur on male rat bladder urothelium

Cross-species Comparison of Orthologous Gene Expression in Human Bladder Cancer and Carcinogen-Induced Rodent Models.

Effect of sodium saccharin and L-tryptophan on rat urine during bladder carcinogenesis

The aetiology of gastric stump carcinoma in the rat

Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder

Urothelial hyperplasia with calculi (papillomatosis) in the urinary bladder of a male spontaneous diabetic Torii rat

Effects of Inorganic Arsenic on the Rat and Mouse Urinary Bladder

Deregulation of the p16-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway involved in the rat bladder carcinogenesis induced by terephthalic acid-calculi

A Novel Mouse Model for Colitis-Associated Colon Carcinogenesis Induced by 1,2-Dimethylhydrazine and Dextran Sulfate Sodium

Rat strains differ in susceptibility to Ureaplasma parvum-induced urinary tract infection and struvite stone formation

Preconditioning methods influence tumor property in an orthotopic bladder urothelial carcinoma rat model

Rat Tumour Histopathology Associated with Experimental Chronic Dietary Exposure to Ochratoxin A in Prediction of the Mycotoxin's Risk for Human Cancers

Helicobacter pylori infection and gastric carcinogenesis in rodent models

[Etiology of bladder cancer]

Morphological lesions of the rat urinary tract induced by inoculation of mycoplasmas and other urinary tract pathogens

Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists

Struvite urolithiasis in a B6C3F1 mouse

Uric acid stones in the urinary bladder of aryl hydrocarbon receptor (AhR) knockout mice

Elevated Urinary Urea by High-Protein Diet Could Be One of the Inducements of Bladder Disorders

Reactions to vesical foreign bodies in two strains of rats